About Transcription initiation factor TFIID subunit 7
Transcription initiation factor TFIID subunit 7 (TAF7) is a protein
from Homo sapiens identified by UniProt accession
Q15545, 349 residues long.
MolForge cross-references it against 0 known binders and
35 disease associations.
Target properties
| Protein name | Transcription initiation factor TFIID subunit 7 |
| UniProt accession | Q15545 |
| Gene | TAF7 |
| Organism | Homo sapiens |
| Length | 349 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (35)
Diseases linked to this target (Open Targets).
- HIV infection · score 0.58
- breast adenocarcinoma · score 0.25
- glioblastoma multiforme · score 0.25
- neurodegenerative disease · score 0.24
- head and neck squamous cell carcinoma · score 0.18
- esophageal cancer · score 0.15
- small cell lung carcinoma · score 0.14
- mean platelet volume · score 0.12
- nonpapillary renal cell carcinoma · score 0.07
- glioblastoma · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q15545-F1 | alphafold | PREDICTED | 76.07 | — |
Amino-acid sequence (349 residues)
MSKSKDDAPH ELESQFILRL PPEYASTVRR AVQSGHVNLK DRLTIELHPD GRHGIVRVDR VPLASKLVDL PCVMESLKTI DKKTFYKTAD ICQMLVSTVD GDLYPPVEEP VASTDPKASK KKDKDKEKKF IWNHGITLPL KNVRKRRFRK TAKKKYIESP DVEKEVKRLL STDAEAVSTR WEIIAEDETK EAENQGLDIS SPGMSGHRQG HDSLEHDELR EIFNDLSSSS EDEDETQHQD EEDINIIDTE EDLERQLQDK LNESDEQHQE NEGTNQLVMG IQKQIDNMKG KLQETQDRAK RQEDLIMKVE NLALKNRFQA VLDELKQKED REKEQLSSLQ EELESLLEK
Explore Transcription initiation factor TFIID subunit 7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets